1700074P13Rik Inhibitors comprise a range of compounds linked to modulating the protein encoded by the 1700074P13Rik gene, known as Prss59. This classification, while speculative, is grounded in a strategic approach to molecular biology and pharmacology, where compounds are identified for their potential to interact with cellular processes and pathways that the Prss59 protein are involved in. The inhibitors in this class are not selected for their direct interaction with Prss59, but rather for their established roles in influencing cellular signaling pathways and biochemical reactions that could, in turn, modulate the function or expression of Prss59. This approach is typical in the early stages of research into a protein's function, particularly when direct targets or mechanisms of action are not well-defined.
The compounds within this chemical class encompass a variety of biochemical agents, each with known roles in modulating specific cellular mechanisms. For instance, kinase inhibitors such as Rapamycin (an mTOR inhibitor) and PD98059 (an ERK pathway inhibitor) are included for their roles in regulating cell growth, proliferation, and differentiation. These processes could intersect with the functional pathways of Prss59, suggesting potential indirect interactions. Similarly, LY294002, a PI3K inhibitor, and SB203580, a p38 MAP kinase inhibitor, are part of this class due to their effects on signaling cascades like phosphatidylinositol signaling and inflammatory responses, which could be relevant to Prss59. Other members of the class, such as Forskolin, W-7 Hydrochloride, and BAPTA, target the modulation of intracellular cAMP and calcium levels, respectively. These compounds could indirectly impact Prss59 by altering the signaling dynamics within the cell. Additionally, this class includes Thapsigargin, a SERCA pump inhibitor, and Genistein, a tyrosine kinase inhibitor, further reflecting the diversity of mechanisms through which these compounds might interact with Prss59-related pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor; has shown to influence cell growth and survival pathways potentially linked to Prss59. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
ERK inhibitor; has shown to impact cell proliferation and differentiation pathways involving Prss59. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor; has shown to alter phosphatidylinositol signaling, affecting Prss59. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAP kinase inhibitor; has shown to modify inflammatory and stress response pathways involving Prss59. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin antagonist; has shown to affect calcium signaling, impacting Prss59. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Modulates IP3 receptor and store-operated calcium channels, affecting calcium signaling. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Calcium chelator; has shown to reduce intracellular calcium, impacting Prss59. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
SERCA pump inhibitor; has shown to elevate cytosolic calcium, impacting pathways related to Prss59. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor; has shown to affect phosphorylation status in pathways involving Prss59. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Protein kinase inhibitor; has shown to influence signaling pathways involving Prss59. | ||||||